TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33974020

Group type: EXPERIMENTAL
Intervention: Internet-delivered CBT (stepped-care group) for 16 weeks
Number of subjects: 152

Group type: COMPARATOR
Intervention: In-person CBT (control group) for 16 weeks
Number of subjects: 152
Study: 32306792

Group type: EXPERIMENTAL
Intervention: BMS‐986166 (0.25 mg)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: BMS‐986166 (0.75 mg)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: BMS‐986166 (1.5 mg)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 34933842

Group type: EXPERIMENTAL
Intervention: 200 mg/day of full-spectrum hyaluronan (FS-HA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36344917

Group type: EXPERIMENTAL
Intervention: Bupivacaine + 1 µg/kg dexmedetomidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine + 1 µg/kg fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine + normal saline
Number of subjects: 60
Study: 36049647

Group type: EXPERIMENTAL
Intervention: VPA-Li
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34471960

Group type: EXPERIMENTAL
Intervention: Ipatasertib 600 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ipatasertib (fed state)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ipatasertib (dose range 200-800 mg)
Number of subjects: 24
Study: 34791761

Group type: EXPERIMENTAL
Intervention: Commercial smartwatch with blood pressure-monitoring feature
Number of subjects: 60

Group type: COMPARATOR
Intervention: Commercial smartwatch without blood pressure-monitoring feature
Number of subjects: 60
Study: 33308134

Group type: EXPERIMENTAL
Intervention: Sjogren's syndrome
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: More than one diagnosis
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: All patients except those with PsA
Number of subjects: 216
Study: 34984792

Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg (OMA300)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Omalizumab 150 mg (OMA150)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 34910825

Group type: EXPERIMENTAL
Intervention: OFD+ABG+L-PRF
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: OFD+ABG
Number of subjects: 54

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 54
Study: 33591279

Group type: EXPERIMENTAL
Intervention: Food4toddlers eHealth intervention (access to website for 6 months)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 298
Study: 34217102

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention by telephone (BMI)
Number of subjects: 0
Study: 36155370

Group type: EXPERIMENTAL
Intervention: Monopolar diathermy
Number of subjects: 234

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 234

Group type: COMPARATOR
Intervention: Comparison of diathermy to scalpel
Number of subjects: 234
Study: 32285996

Group type: EXPERIMENTAL
Intervention: UV lens replacement during blue-enriched light exposure
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: BB lens replacement during blue-enriched light exposure
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-cataract controls during blue-enriched light exposure
Number of subjects: 29
Study: 35213484

Group type: EXPERIMENTAL
Intervention: TIVA with propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 0
Study: 33415743

Group type: EXPERIMENTAL
Intervention: CART algorithm for classifying severity of malnutrition
Number of subjects: 3998

Group type: EXPERIMENTAL
Intervention: CART model performance in validation group
Number of subjects: 3998

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of CART model
Number of subjects: 3998
Study: 33660386

Group type: EXPERIMENTAL
Intervention: Homeopathic Treatment as an Add-On Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35672726

Group type: EXPERIMENTAL
Intervention: Combination condition (30% price increase + information nudge)
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Price condition (30% price increase for meat)
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Information nudge condition (information about environmental impact of meat production)
Number of subjects: 533

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 533
Study: 36031405

Group type: EXPERIMENTAL
Intervention: Recombinant-HA influenza vaccine (RIV) in 2 consecutive seasons
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Cell culture-based inactivated influenza vaccine (ccIIV) in 2 consecutive seasons
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: RIV/ccIIV
Number of subjects: 414

Group type: COMPARATOR
Intervention: IIV/IIV
Number of subjects: 414
Study: 34014991

Group type: EXPERIMENTAL
Intervention: Good knowledge about diabetes
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Higher educational status
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Overall attitude towards diabetes
Number of subjects: 626
Study: 33482949

Group type: EXPERIMENTAL
Intervention: Text reminders
Number of subjects: 4545

Group type: COMPARATOR
Intervention: No preference for reminder type
Number of subjects: 4545
Study: 36498690

Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Manual Therapy (IAMT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Heat application (comparison group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Pressure-less placebo (placebo group)
Number of subjects: 67
Study: 32687762

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate prehydration
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prehydration
Number of subjects: 0
Study: 34435429

Group type: EXPERIMENTAL
Intervention: EVOO-enriched chocolate spread
Number of subjects: 20

Group type: COMPARATOR
Intervention: Palm oil-enriched chocolate spread
Number of subjects: 20
Study: 32068582

Group type: EXPERIMENTAL
Intervention: Early mobilization in neurocritical care patients
Number of subjects: 0
Study: 33617382

Group type: EXPERIMENTAL
Intervention: Total joint replacement (TJR) surgery
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Current therapy satisfaction
Number of subjects: 339
Study: 34244006

Group type: COMPARATOR
Intervention: RV3 rotavirus vaccine (Bio Farma) in neonates
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: RV3 rotavirus vaccine (Bio Farma) in adults and children
Number of subjects: 100
Study: 35177687

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: % fat mass
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Fat mass index
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Fat-free mass index
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Greater cardiorespiratory fitness
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Motor fitness
Number of subjects: 411
Study: 33600060

Group type: EXPERIMENTAL
Intervention: Group A: 2 g/kg IVIG once
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Group B: 1 g/kg IVIG for 2 consecutive days
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Group C: 1 g/kg IVIG once
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control: Aspirin 30 mg/kg/d
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 404
Study: 32282467

Group type: EXPERIMENTAL
Intervention: Inhaled methoxyflurane plus standard of care (m-SoC) analgesia
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo plus standard of care (p-SoC)
Number of subjects: 351
Study: 36038131

Group type: EXPERIMENTAL
Intervention: RDS (Reliever Digihaler System)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 333
Study: 34391961

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels assessed using the Baecke Questionnaire of Habitual Physical Activity
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Physical Activity indices (work index, sport index, leisure-time index, total activity index)
Number of subjects: 100
Study: 33214515

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary resuscitation coach
Number of subjects: 200

Group type: COMPARATOR
Intervention: Noncoach clinical provider
Number of subjects: 200
Study: 32068688

Group type: EXPERIMENTAL
Intervention: NT-814 50 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: NT-814 100 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: NT-814 150 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: NT-814 300 mg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 35135060

Group type: EXPERIMENTAL
Intervention: Direct endovascular thrombectomy
Number of subjects: 780

Group type: COMPARATOR
Intervention: Standard bridging IV thrombolysis followed by endovascular thrombectomy
Number of subjects: 780
Study: 33513636

Group type: EXPERIMENTAL
Intervention: Bilateral vaginal sacrospinous fixation with anterior mesh (VSF-AM group; n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Abdominal sacrocolpopexy (ASC group; n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both surgeries (VSF-AM and ASC)
Number of subjects: 40
Study: 35537640

Group type: EXPERIMENTAL
Intervention: Consultations with patients with AAA
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Consultations with patients with IC
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Consultations with patients with VV
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Consultations by a resident in training or nurse practitioner
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Consultations by a nurse practitioner
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Consultations longer than 30 minutes
Number of subjects: 342
Study: 33612644

Group type: EXPERIMENTAL
Intervention: Catfish oil enriched with omega-3 (CO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Soybean oil (SO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Commercial fish oil (CFO)
Number of subjects: 29
Study: 34806658

Group type: EXPERIMENTAL
Intervention: i.v. lidocaine (1.5 mg/kg later 2 mg/kg/hour)
Number of subjects: 40
Study: 34154439

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (capsule-delivered)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 32270927

Group type: EXPERIMENTAL
Intervention: Time-Restricted Eating (TRE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-Time-Restricted Eating (non-TRE)
Number of subjects: 20
Study: 34850043

Group type: EXPERIMENTAL
Intervention: GnRHa triptorelin
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control arm (chemotherapy alone)
Number of subjects: 281
Study: 32304151

Group type: EXPERIMENTAL
Intervention: Walking (≥10,000 steps on school holidays)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Limiting screen time (<90 min on weekdays and <150 min on school holidays)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Walking vs Control
Number of subjects: 190
Study: 35170401

Group type: EXPERIMENTAL
Intervention: Targeted videos
Number of subjects: 1353

Group type: EXPERIMENTAL
Intervention: Tailored videos
Number of subjects: 1353

Group type: COMPARATOR
Intervention: Generic videos
Number of subjects: 1353
Study: 34272817

Group type: EXPERIMENTAL
Intervention: Hesperidin-enriched orange juice (EOJ)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 159
Study: 36180564

Group type: EXPERIMENTAL
Intervention: Medium cut-off membranes (MCO)
Number of subjects: 46

Group type: COMPARATOR
Intervention: High flux-HD
Number of subjects: 46
Study: 32976331

Group type: EXPERIMENTAL
Intervention: Oral and visual education with photographs (in-person)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Oral and visual education with photographs (video)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Oral only education
Number of subjects: 103
Study: 32660442

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs) and Controlled Clinical Trials (CCTs)
Number of subjects: 380
Study: 35956364

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) adherence
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: High adherence to the Mediterranean diet
Number of subjects: 138
Study: 33607831

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple nerve blocks (intercostal nerve blocks, interscalene brachial plexus, and supraclavicular nerve blocks) with local anesthesia (0.3% ropivacaine: 5 ml for each intercostal nerve block, 8 ml for brachial plexus block, 7 ml for supraclavicular nerve block) and basic sedation.
Number of subjects: 80

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 80
Study: 35669353

Group type: EXPERIMENTAL
Intervention: Ivermectin 12 mg (Iv12)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ivermectin 24 mg (Iv24)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard of care (Control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: All treatment groups (Iv12, Iv24, Control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Moderate illness
Number of subjects: 112
Study: 34538402

Group type: COMPARATOR
Intervention: Active monitoring for one year (Arm A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Durvalumab (PD-L1 inhibitor) 4-weekly for one year (Arm B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with durvalumab 4-weekly for one year plus two doses of tremelimumab (CTLA-4 inhibitor) at day 1 of the first two 4-weekly cycles (Arm C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active monitoring (Arm A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Durvalumab (Arm B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (Arm C)
Number of subjects: 0
Study: 33950573

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 7020
Study: 32000825

Group type: EXPERIMENTAL
Intervention: Metoprolol at a target dose of 100 mg per day
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Standard COPD care only
Number of subjects: 1700
Study: 34564893

Group type: EXPERIMENTAL
Intervention: Tenecteplase
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 1100
Study: 33535060

Group type: EXPERIMENTAL
Intervention: Taping cloth masks while speaking
Number of subjects: 13

Group type: COMPARATOR
Intervention: No taping of cloth masks while speaking
Number of subjects: 13

Group type: COMPARATOR
Intervention: Taping cloth masks during normal or deep breathing
Number of subjects: 13

Group type: COMPARATOR
Intervention: Taping surgical or N95 masks
Number of subjects: 13
Study: 35670036

Group type: EXPERIMENTAL
Intervention: pembrolizumab plus low-dose SNK01 (2 × 10^9 cells/dose)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: pembrolizumab plus high-dose SNK01 (4 × 10^9 cells/dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: pembrolizumab monotherapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: pembrolizumab plus SNK01
Number of subjects: 20
Study: 34030638

Group type: EXPERIMENTAL
Intervention: Yogurt group (n=479)
Number of subjects: 961

Group type: COMPARATOR
Intervention: Control group (n=482)
Number of subjects: 961
Study: 33242419

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Amantadine (up to 100 mg twice daily)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Modafinil (up to 100 mg twice daily)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Methylphenidate (up to 10 mg twice daily)
Number of subjects: 141
Study: 32080092

Group type: EXPERIMENTAL
Intervention: NMES+SWD and supervised exercises
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham group with supervised exercise alone
Number of subjects: 20
Study: 35867627

Group type: EXPERIMENTAL
Intervention: MBE plus lid hygiene
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lid hygiene alone
Number of subjects: 50
Study: 33588378

Group type: COMPARATOR
Intervention: Presleep protein ingestion (40 g intrinsically L-[1-13C]-phenylalanine and L-[1-13C]-leucine-labeled casein protein)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercise plus presleep protein ingestion (40 g intrinsically-labeled casein protein after resistance-type exercise)
Number of subjects: 36
Study: 35888667

Group type: EXPERIMENTAL
Intervention: Maximum Voluntary Isometric Contraction (MVIC)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: MVIC-based prediction of 1RM
Number of subjects: 328
Study: 34686472

Group type: EXPERIMENTAL
Intervention: R-miniCHOP chemoimmunotherapy with oral azacitidine (CC-486)
Number of subjects: 422

Group type: COMPARATOR
Intervention: R-miniCHOP chemoimmunotherapy without oral azacitidine (CC-486)
Number of subjects: 422
Study: 32469156

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1767
Study: 35986303

Group type: EXPERIMENTAL
Intervention: Sensory Integration Therapy (SIT)
Number of subjects: 0
Study: 33358232

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen/1,000 mg acetaminophen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 800 mg ibuprofen/1,000 mg acetaminophen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 30 mg codeine/300 mg acetaminophen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 5 mg hydrocodone/300 mg acetaminophen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 5 mg oxycodone/325 mg acetaminophen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Opioids (codeine, hydrocodone, oxycodone)
Number of subjects: 600
Study: 36027955

Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous amoxicillin and clavulanic acid
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanic acid administration
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Episiotomy
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Forceps
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Primiparity
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Body mass index of 25.0 to 29.9 kg/m2
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Body mass index of ≥30 kg/m2
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Timing of antibiotic administration
Number of subjects: 3225
Study: 33108743

Group type: EXPERIMENTAL
Intervention: Linear Periodization (LP) aerobic training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nonlinear Periodization (NLP) aerobic training
Number of subjects: 39
Study: 32245518

Group type: EXPERIMENTAL
Intervention: Robotic radical antegrade modular pancreatosplenectomy (RAMPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard retrograde pancreatosplenectomy (SRPS)
Number of subjects: 0
Study: 35794079

Group type: EXPERIMENTAL
Intervention: HN0037 (10, 30, 60, 120, 200, 300, and 400 mg single doses; 30 and 100 mg once daily for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HN0037
Number of subjects: 0
Study: 33752121

Group type: EXPERIMENTAL
Intervention: Relaxin levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ca125, HE4, and ROMA levels
Number of subjects: 0
Study: 34110862

Group type: EXPERIMENTAL
Intervention: Simple olfactory training (OT) utilizing single-molecule odors
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Mixtures olfactory training (OT) using odor mixtures
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group without OT
Number of subjects: 68
Study: 34740836

Group type: COMPARATOR
Intervention: Mechanical debridement (MD) alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: MD at baseline followed by a single session of adjunct aPDT
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: MD at baseline followed by aPDT at baseline and at 3-month follow-up
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: MD at baseline followed by aPDT at baseline and at 3- and 6-month follow-up
Number of subjects: 88
Study: 33453159

Group type: EXPERIMENTAL
Intervention: Conjunctival autograft (CAG)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) with postoperative interferon alfa‐2b (IFN alfa‐2b)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Modified conjunctival autograft plus amniotic membrane transplantation (mCAG plus AMT) with postoperative IFN alfa‐2b
Number of subjects: 85
Study: 32713706

Group type: EXPERIMENTAL
Intervention: Live yeast culture
Number of subjects: 45

Group type: COMPARATOR
Intervention: No yeast
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alfalfa haylage (AH)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Corn silage (CS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Grass hay (GH)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Forage offered
Number of subjects: 45
Study: 35344474

Group type: EXPERIMENTAL
Intervention: Online hypnotic intervention for 7 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 20
Study: 34144695

Group type: EXPERIMENTAL
Intervention: Active intervention group (counseling by primary care physicians and patient education pamphlets)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Passive intervention group (only patient education pamphlets)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 188
Study: 33109578

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific regimen not detailed)
Number of subjects: 569
Study: 36058995

Group type: EXPERIMENTAL
Intervention: Novel ablation confirmation (AC) method for ablation applicator(s) placement verification and MAM assessment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Visual inspection and anatomical landmarks-based quantitative measurements
Number of subjects: 100
Study: 33549557

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (Xarelto)
Number of subjects: 3224